Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹381 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹381 Cr
Mar2024₹314 Cr
Mar2023₹266 Cr
Mar2022₹185 Cr
Mar2021₹236 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹381 Cr
21.32
Mar2024 ₹314 Cr
17.80
Mar2023 ₹266 Cr
44.29
Mar2022 ₹185 Cr
-21.77
Mar2021 ₹236 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,363.8 Cr 1.6% 12% -31.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,170.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr -4.1% -3.8% -4.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.6%

12%

-31.6%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses